 |
Covid-19 - AND SEE BOTTOM LEFT OF THIS PAGE
- Covid-19: Guidance for the public here.
- Covid-19: Guidance for HCPs here.
During the Covid-19 outbreak, clinicians in England should submit reports of suspected side effects to medicines or medical devices using the Yellow Card Scheme electronically (rather than by paper) via the Yellow Card website or the free Yellow Card app [from the Apple App Store or Google Play Store] to enable early identification of trends.
01/04/2020 |
|
|
|
|
|
25th March 2020 - MHRA statement on cloroquine and hydroxychloroquine for COVID-19 - Until we have clear, definitive evidence that these treatments are safe and effective for the treatment of COVID-19, chloroquine and hydroxychloroquine should only be used for this purpose within a clinical trial.
01/04/2020 |
|
|
|
|
|
Mar 2020 - Ulipristal (Esmya) removed from formulary: suspension of license due to risk of serious liver injury
20/03/2020 |
|
|
|
|
|
Mar 2020 - MHRA DSU Baricitinib (Olumiant▼): risk of venous thromboembolism
20/03/2020 |
|
|
|
|
|
Jan 2020 - Note - Discontinuation of 3 Insuman presentations (recombinant human insulin).
05/02/2020 |
|
|
|
|
|
Jan 2020 - Ingenol mebutate (Picato®) gel has been removed from the formulary and the BSW Actinic keratoses pathway as a precautionary measure following the MHRA Class 2 recall
29/01/2020 |
|
|
|
|
|
Jan 2020 - MHRA Drug Safety Update Ondansetron - Small increased risk of oral clefts following use in the first 12 weeks of pregnancy
29/01/2020 |
|
|
|
|
|
Dec 2019 - Ranitidine - Supply Disruption Alert – SECOND UPDATE - all oral formulations (open PDF in link)
This additional document produced by SFT may be helpful for paediatric queries PPIs IN PAEDIATRICS
20/12/2019 |
|
|
|
|
|
December 2019 - BSW cannabis-based medicinal products - interim position statement in response to publication of NICE guideline that covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
11/12/2019 |
|
|
|
|
|
December 2019 - Prescribers may now prescribe and pharmacists may now supply antiviral medicines for the prophylaxis and treatment of influenza at NHS expense. See here
03/12/2019 |
|
|
|
|
|
November 2019: Slo-phyllin (Theophylline) 60mg/125mg/500mg capsules out of stock by end November 2019. See here for MHRA advice on management of patients currently using this medicine.
28/11/2019 |
|
|
|
|
|
October 2019 - Drug Safety Update - Prescribing medicines in renal impairment: using the appropriate estimate of renal function to avoid the risk of adverse drug reactions
24/10/2019 |
|
|
|
|
|
October 2019 - Shortage of phenelzine (Nardil) tablets
16/10/2019 |
|
|
|
|
|
Updated Sep 25th 2019 - Hormone Replacement Therapy (HRT) Supply Issues
03/10/2019 |
|
|
|
|
